Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:AMIXNASDAQ:CHEKNASDAQ:NAYANASDAQ:VERO On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAMIXAutonomix Medical$1.41-7.2%$1.66$1.14▼$42.40$3.92M-2.99519,311 shs127,712 shsCHEKCheck-Cap$0.73-2.4%$0.82$0.56▼$3.04$4.29M0.19380,942 shs11,686 shsNAYANAYA Biosciences$0.86-1.3%$1.61$1.38▼$17.04$575K2.0353,151 shs54,365 shsVEROVenus Concept$2.62-11.4%$2.41$2.10▼$14.50$3.71M0.07693,001 shs241,125 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAMIXAutonomix Medical0.00%-29.85%-4.73%-12.42%-88.98%CHEKCheck-Cap0.00%-4.05%-8.54%+13.01%-63.48%NAYANAYA Biosciences0.00%-5.86%-45.66%-58.79%+86,399,900.00%VEROVenus Concept0.00%+19.95%-17.77%+6.30%-62.37%Compare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAMIXAutonomix Medical3.0351 of 5 stars3.52.00.00.03.01.71.3CHEKCheck-Cap0.4526 of 5 stars0.05.00.00.00.00.00.6NAYANAYA BiosciencesN/AN/AN/AN/AN/AN/AN/AN/AVEROVenus Concept0.9934 of 5 stars0.02.00.00.02.03.30.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAMIXAutonomix Medical 3.00Buy$16.501,070.21% UpsideCHEKCheck-Cap 0.00N/AN/AN/ANAYANAYA Biosciences 3.00Buy$24.002,677.78% UpsideVEROVenus Concept 0.00N/AN/AN/ACurrent Analyst Ratings BreakdownLatest NAYA, CHEK, AMIX, and VERO Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails4/29/2025AMIXAutonomix MedicalMaxim GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingInitiated CoverageBuy$5.00(Data available from 7/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAMIXAutonomix MedicalN/AN/AN/AN/A$3.29 per shareN/ACHEKCheck-CapN/AN/AN/AN/A$4.05 per shareN/ANAYANAYA Biosciences$6.23M0.09N/AN/A($2.06) per share-0.42VEROVenus Concept$64.83M0.06N/AN/A$4.30 per share0.61Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAMIXAutonomix Medical-$11.41M-$7.47N/AN/AN/AN/A-174.70%-133.35%N/ACHEKCheck-Cap-$17.57M-$3.00N/A∞N/AN/AN/AN/AN/ANAYANAYA Biosciences-$8.03MN/A0.00∞N/A-119.91%N/A-41.72%8/12/2025 (Estimated)VEROVenus Concept-$47M-$76.30N/A∞N/A-81.26%-752.29%-54.52%8/12/2025 (Estimated)Latest NAYA, CHEK, AMIX, and VERO EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/29/2025Q4 2025AMIXAutonomix MedicalN/A-$0.74N/A-$0.74N/AN/A5/15/2025Q1 2025VEROVenus Concept-$14.08-$17.44-$3.36-$17.44$14.59 million$13.64 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAMIXAutonomix MedicalN/AN/AN/AN/AN/ACHEKCheck-CapN/AN/AN/AN/AN/ANAYANAYA BiosciencesN/AN/AN/AN/AN/AVEROVenus ConceptN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAMIXAutonomix MedicalN/A5.635.63CHEKCheck-CapN/AN/AN/ANAYANAYA BiosciencesN/A0.230.20VEROVenus Concept7.911.280.79Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAMIXAutonomix Medical10.78%CHEKCheck-Cap1.07%NAYANAYA Biosciences12.02%VEROVenus Concept87.41%Insider OwnershipCompanyInsider OwnershipAMIXAutonomix Medical32.40%CHEKCheck-Cap0.48%NAYANAYA Biosciences1.79%VEROVenus Concept28.04%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAMIXAutonomix Medical12.78 million1.88 millionN/ACHEKCheck-Cap805.85 million5.82 millionNot OptionableNAYANAYA Biosciences10666,0004.40 millionN/AVEROVenus Concept4101.42 million1.03 millionNot OptionableNAYA, CHEK, AMIX, and VERO HeadlinesRecent News About These CompaniesVenus Concept Executes Debt-to-Equity Exchange AgreementJuly 1, 2025 | tipranks.comVenus Concept Announces $6.5 Million Debt-to-Equity Exchange TransactionJuly 1, 2025 | globenewswire.comVenus Concept Inc News (VERO) - Investing.comJune 26, 2025 | investing.comVenus Concept Stock Climbs After Stock Offering ClosesJune 9, 2025 | marketwatch.comVenus Concept Inc. Closes Registered Direct Offering and Private Placement Raising Approximately $1.15 MillionJune 9, 2025 | quiverquant.comQVenus Concept Announces Closing of Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 9, 2025 | globenewswire.comVenus Concept To Sell Hair Business To Meta Healthcare In $20M All-Cash DealJune 8, 2025 | nasdaq.comVenus Concept prices $3.45M in direct offering, warrants; shares up over 29%June 7, 2025 | msn.comVenus Concept Stock Is Soaring On Friday - Here's WhyJune 7, 2025 | aol.comAVenus Concept Sells Hair Business to Meta HealthcareJune 6, 2025 | tipranks.comVenus Concept Stock Is Soaring On Friday - Here's WhyJune 6, 2025 | benzinga.comVenus Concept Inc.: Venus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 MillionJune 6, 2025 | finanznachrichten.deVenus Concept Shares Soar on Sale of Hair BusinessJune 6, 2025 | marketwatch.comVenus Concept Announces Up To $3.45 Million Registered Direct Offering Priced At-The-Market Under Nasdaq RulesJune 6, 2025 | globenewswire.comVenus Concept Inc. Sells Venus Hair Business to Meta Healthcare Group in $20 Million DealJune 6, 2025 | quiverquant.comQVenus Concept to sell Venus Hair business for $20M, stock soars 50%June 6, 2025 | msn.comVenus Concept Announces Definitive Agreement to Sell Venus Hair Business for $20 MillionJune 6, 2025 | globenewswire.comVenus Concept Announces First Quarter 2025 Financial ResultsMay 16, 2025 | theglobeandmail.comVenus Concept Inc (VERO) Q1 2025 Earnings Call Highlights: Navigating Revenue Declines Amid ...May 16, 2025 | finance.yahoo.comVenus Concept Inc. (NASDAQ:VERO) Q1 2025 Earnings Call TranscriptMay 16, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeNAYA, CHEK, AMIX, and VERO Company DescriptionsAutonomix Medical NASDAQ:AMIX$1.41 -0.11 (-7.24%) Closing price 07/3/2025 03:51 PM EasternExtended Trading$1.40 -0.01 (-0.71%) As of 04:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.Check-Cap NASDAQ:CHEK$0.73 -0.02 (-2.42%) Closing price 07/3/2025 12:36 PM EasternExtended Trading$0.75 +0.02 (+2.72%) As of 07/3/2025 04:35 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. Check-Cap Ltd. was incorporated in 2004 and is based in Isfiya, Israel.NAYA Biosciences NASDAQ:NAYA$0.86 -0.01 (-1.31%) As of 07/3/2025NAYA Biosciences is a life science portfolio company dedicated to bringing breakthrough treatments to patients in oncology, autoimmune diseases and fertility. NAYA Biosciences, formerly known as INVO BIOSCIENCE, is based in SARASOTA, Fla.Venus Concept NASDAQ:VERO$2.62 -0.34 (-11.36%) Closing price 07/3/2025 03:51 PM EasternExtended Trading$2.58 -0.04 (-1.53%) As of 04:16 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Venus Concept Inc., a medical technology company, develops, commercializes, and delivers minimally invasive and non-invasive medical aesthetic and hair restoration technologies, and related services in the United States and internationally. Its product portfolio includes Venus Legacy, a noninvasive device used in dermatological and general surgical procedures for females; Venus Versa, a multi-application device used in aesthetic and cosmetic procedures; Venus Versa Pro; and Venus Viva and Venus Viva MD, an advanced, portable, and fractional RF system for dermatological procedures requiring ablation and resurfacing of the skin. The company also offers Venus Fiore, a device that delivers non-thermal RF with massage and magnetic field pulses to treat various medical conditions; Venus Bliss and Venus Bliss Max for non-invasive lipolysis of the abdomen, back, thights, and flanks in individuals with a body mass index of 30 or less; Venus Glow, a dermabrasion device used to improve skin appearance; and NeoGraft, an advanced hair restoration technology with an automated FUE and implantation system. In addition, it provides Venus Velocity and Venus Epileve for hair removal, permanent hair reduction, and treatment of pseudofolliculitis barbae; ARTAS iX, a robotic system to assist physicians in identifying and extracting hair follicles units from the scalp during hair transplantation, creating recipient sites, and implanting the harvested hair follicles; and AI.ME an interactive, image-guided, and computer assisted system for fractional skin resurfacing. The company is headquartered in Toronto, Canada. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas MarketBeat Week in Review – 06/30 - 07/04 The Apple Comeback Will Be Better Than the Setback Micron’s Big Q3 Drives Applied Materials’ Bullish Outlook Correction Equals Opportunity in Domino’s Pizza Stock Why Occidental's Price Dip Signals a Buying Opportunity Qualcomm’s Hold Rating Misses Strong Growth Story Rigetti Computing: Cantor's Bullish Call May Be Just the Start Insider Selling at NVIDIA Could Turn Into an Opportunity Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
